{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:48:58Z","timestamp":1775807338757,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jacbts.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T18:40:26Z","timestamp":1663785626000},"page":"985-997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasminogen Activator Inhibitor-1\u2013Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype"],"prefix":"10.1016","volume":"7","author":[{"given":"Richard G.","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Claire","family":"Duchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Simard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Di Santo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisha","family":"Labinaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Daniel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Robichaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Ouimet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer","family":"Short","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxia","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Lordkipanidz\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Gadde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katey J.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Hibbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2022.05.002_bib1","first-page":"35","article-title":"The evolution of coronary stents: a brief review","volume":"30","author":"Simard","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib2","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2022.05.002_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijcard.2013.01.234","article-title":"Three year clinical outcomes with zotarolimus (Endeavor) drug-eluting stents in an unrestricted contemporary practice","volume":"168","author":"Giles","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2022.05.002_bib6","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/eurheartj\/ehv511","article-title":"Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gr\u00fcntzig Lecture ESC 2014","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2022.05.002_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2018.02.135","article-title":"Role of plasminogen activator inhibitor-1 in coronary pathophysiology","volume":"164","author":"Jung","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacbts.2022.05.002_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12959-018-0166-4","article-title":"Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis","volume":"16","author":"Jung","year":"2018","journal-title":"Thrombosis J"},{"key":"10.1016\/j.jacbts.2022.05.002_bib9","doi-asserted-by":"crossref","first-page":"17714","DOI":"10.1038\/srep17714","article-title":"Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies","volume":"6","author":"Yarmolinsky","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2022.05.002_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2020.04.025","article-title":"Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention","volume":"191","author":"Jung","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacbts.2022.05.002_bib11","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood-2004-04-1439","article-title":"Platelets synthesize large amounts of active plasminogen activator inhibitor 1","volume":"104","author":"Brogren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2022.05.002_bib12","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/ATVBAHA.116.308344","article-title":"Pharmacological targeting of plasminogen activator inhibitor-1 decreases vascular smooth muscle cell migration and neointima formation","volume":"36","author":"Ji","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib13","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/jth.13869","article-title":"Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin","volume":"15","author":"Luo","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacbts.2022.05.002_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172558","article-title":"Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity","volume":"12","author":"Chiva-Blanch","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2022.05.002_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2015.09.011","article-title":"Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time","volume":"202","author":"Suades","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124904","article-title":"Release of intracoronary microparticles during stent implantation into stable atherosclerotic lesions under protection with an aspiration device","volume":"10","author":"Horn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2022.05.002_bib17","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1007\/s00018-018-2771-6","article-title":"Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculome","volume":"75","author":"De Paoli","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jacbts.2022.05.002_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2013-03-492801","article-title":"Activated platelets can deliver mRNA regulatory Ago2\u2022microRNA complexes to endothelial cells via microparticles","volume":"122","author":"Laffont","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2022.05.002_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1160\/th15-05-0389","article-title":"Platelet microparticles reprogram macrophage gene expression and function","volume":"115","author":"Laffont","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacbts.2022.05.002_bib20","doi-asserted-by":"crossref","first-page":"1322454","DOI":"10.1080\/20013078.2017.1322454","article-title":"Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype","volume":"6","author":"Vajen","year":"2017","journal-title":"J\u00a0Extracell Vesicles"},{"key":"10.1016\/j.jacbts.2022.05.002_bib21","doi-asserted-by":"crossref","first-page":"E3564","DOI":"10.1073\/pnas.1507905112","article-title":"Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA","volume":"112","author":"Duchez","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2022.05.002_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood-2016-11-751099","article-title":"Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth","volume":"130","author":"Michael","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2022.05.002_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1479164119845123","article-title":"Performance of plasminogen activator inhibitor-1 as a biomarker in patients undergoing coronary angiography: analytical and biological considerations","author":"Jung","year":"2019","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.jacbts.2022.05.002_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bimj.200710415","article-title":"Youden index and optimal cut-point estimated from observations affected by a lower limit of detection","volume":"50","author":"Ruopp","year":"2008","journal-title":"Biometrical J"},{"key":"10.1016\/j.jacbts.2022.05.002_bib25","article-title":"Total Thrombus-Formation Analysis System (T-TAS) can predict periprocedural bleeding events in patients undergoing catheter ablation for atrial fibrillation","volume":"5","author":"Ito","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2022.05.002_bib26","doi-asserted-by":"crossref","first-page":"562481","DOI":"10.1155\/2011\/562481","article-title":"PAI-1: an integrator of cell signaling and migration","volume":"2011","author":"Czekay","year":"2011","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib27","doi-asserted-by":"crossref","first-page":"22595","DOI":"10.1074\/jbc.M313004200","article-title":"The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1","volume":"279","author":"Degryse","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2022.05.002_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.cellsig.2015.01.009","article-title":"A\u00a0small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage","volume":"27","author":"Simone","year":"2015","journal-title":"Cell Signal"},{"key":"10.1016\/j.jacbts.2022.05.002_bib29","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.celrep.2018.10.082","article-title":"Plasminogen activator inhibitor-1 promotes the recruitment and polarization of macrophages in cancer","volume":"25","author":"Kubala","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jacbts.2022.05.002_bib30","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","article-title":"Plasminogen activator inhibitor-1 in cancer: rationale and insight for future therapeutic testing","volume":"75","author":"Placencio","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jacbts.2022.05.002_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ajcp\/96.5.605","article-title":"How vitronectin binds to activated glycoprotein Ilb-IIIa complex and its function in platelet aggregation","volume":"96","author":"Mohri","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/CS20120309","article-title":"Microparticles: biomarkers and beyond","volume":"124","author":"Burger","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacbts.2022.05.002_bib33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra1704286","article-title":"Circulating extracellular vesicles in human disease","volume":"379","author":"Shah","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2022.05.002_bib34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1160\/TH12-07-0486","article-title":"Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques","volume":"108","author":"Suades","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacbts.2022.05.002_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2009.05.022","article-title":"Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease","volume":"54","author":"Nozaki","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jacc.2020.05.057","article-title":"Atherosclerotic cardiovascular disease risk stratification based on measurements of troponin and coronary artery calcium","volume":"76","author":"Sandoval","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib37","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/ehq478","article-title":"Circulating CD31+\/Annexin V+ microparticles correlate with cardiovascular outcomes","volume":"32","author":"Sinning","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2022.05.002_bib38","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1681\/ASN.2005050535","article-title":"Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure","volume":"16","author":"Amabile","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacbts.2022.05.002_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/01.HYP.0000231507.00962.b5","article-title":"Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease","volume":"48","author":"Boulanger","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2022.05.002_bib40","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J\u00a0Extracell Vesicles"},{"key":"10.1016\/j.jacbts.2022.05.002_bib41","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.119.313775","article-title":"Drug targeting of plasminogen activator inhibitor-1 inhibits metabolic dysfunction and atherosclerosis in a murine model of metabolic syndrome","volume":"40","author":"Khoukaz","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:25:20Z","timestamp":1762820720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X22001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2452302X22001851"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2022.05.002","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasminogen Activator Inhibitor-1\u2013Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}